Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China · Delayed Price · Currency is CNY 21.79
-0.05 (-0.23%)
Feb 4, 2026, 11:34 AM CST
SHE:002393 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 386.02 | 184.53 | 361.83 | 93.61 | 122.11 | 8.62 |
Depreciation & Amortization | 79.85 | 79.85 | 67.31 | 66.12 | 60.2 | 63.48 |
Other Amortization | 1.35 | 1.35 | - | - | - | - |
Loss (Gain) From Sale of Assets | 0.05 | 0.05 | -238.7 | 34.82 | - | - |
Asset Writedown & Restructuring Costs | 0.37 | 0.37 | 15.27 | 1.2 | 1.61 | 70.64 |
Loss (Gain) From Sale of Investments | -102.84 | -102.84 | -15.97 | -23.96 | -19.25 | -16.18 |
Provision & Write-off of Bad Debts | 0 | 0 | - | - | - | - |
Other Operating Activities | -149.35 | 19.11 | 14.11 | 19 | 14.08 | 0.53 |
Change in Accounts Receivable | -42.56 | -42.56 | 17.52 | 25.13 | -19.5 | -4.29 |
Change in Inventory | -21.72 | -21.72 | 8.91 | 11.14 | -4.35 | 29.87 |
Change in Accounts Payable | -31.66 | -31.66 | -28.28 | 116.95 | 50.22 | -78.16 |
Change in Other Net Operating Assets | 5.55 | 5.55 | 3.49 | 2.74 | -0.03 | 0.47 |
Operating Cash Flow | 121.29 | 88.26 | 200.01 | 331.38 | 196.34 | 76.37 |
Operating Cash Flow Growth | -42.20% | -55.87% | -39.65% | 68.78% | 157.09% | -71.54% |
Capital Expenditures | -40.36 | -53.75 | -61.72 | -40.91 | -88.24 | -100.66 |
Sale of Property, Plant & Equipment | 0.34 | 0.41 | 253.54 | 115.27 | 0.09 | 0.12 |
Cash Acquisitions | -6.99 | - | -102 | - | - | - |
Investment in Securities | -248.26 | -262.61 | -79.96 | -250.04 | - | -0.75 |
Other Investing Activities | 46.42 | 56.86 | 9.5 | 20.04 | 12.04 | 8.38 |
Investing Cash Flow | -248.86 | -259.09 | 19.36 | -155.64 | -76.12 | -92.92 |
Short-Term Debt Issued | - | 39.75 | - | - | - | 20 |
Total Debt Issued | 25 | 39.75 | - | - | - | 20 |
Short-Term Debt Repaid | - | -47.19 | - | - | - | -40 |
Long-Term Debt Repaid | - | -6.04 | -0.3 | -0.06 | - | - |
Total Debt Repaid | -32.46 | -53.24 | -0.3 | -0.06 | - | -40 |
Net Debt Issued (Repaid) | -7.46 | -13.49 | -0.3 | -0.06 | - | -20 |
Issuance of Common Stock | 61.1 | - | 5.55 | 21.01 | - | - |
Repurchase of Common Stock | -39.59 | -39.59 | - | - | - | - |
Common Dividends Paid | -105.71 | -121.03 | -54.74 | -54.74 | -18.25 | -55.06 |
Other Financing Activities | -90.97 | -0.07 | 0.67 | - | - | - |
Financing Cash Flow | -182.61 | -174.18 | -48.82 | -33.79 | -18.25 | -75.06 |
Foreign Exchange Rate Adjustments | -0 | 0 | - | - | - | - |
Net Cash Flow | -310.19 | -345 | 170.54 | 141.95 | 101.97 | -91.6 |
Free Cash Flow | 80.93 | 34.51 | 138.29 | 290.47 | 108.1 | -24.29 |
Free Cash Flow Growth | -51.08% | -75.04% | -52.39% | 168.71% | - | - |
Free Cash Flow Margin | 6.13% | 2.58% | 11.99% | 25.33% | 9.90% | -2.13% |
Free Cash Flow Per Share | 0.32 | 0.14 | 0.54 | 1.13 | 0.42 | -0.10 |
Cash Income Tax Paid | 197.51 | 154.11 | 195.53 | 133.17 | 126.12 | 156.02 |
Levered Free Cash Flow | -298.09 | 17.39 | 24.69 | 302.3 | 8.51 | -127.96 |
Unlevered Free Cash Flow | -296.29 | 19.05 | 25.16 | 302.85 | 8.71 | -127.63 |
Change in Working Capital | -94.16 | -94.16 | -3.83 | 140.6 | 17.59 | -50.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.